Paul Hopper - Net Worth and Insider Trading
Paul Hopper Net Worth
The estimated net worth of Paul Hopper is at least $11,630 dollars as of 2024-11-10. Paul Hopper is the Director of EyePoint Pharmaceuticals Inc and owns about 1,000 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $11,630. Details can be seen in Paul Hopper's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Hopper has not made any transactions after 2012-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Hopper
Paul Hopper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Hopper owns 3 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , Fibrocell Science Inc (FCSC) , and Scopus BioPharma Inc (SCPS) .
Click here to see the complete history of Paul Hopper’s form 4 insider trades.
Insider Ownership Summary of Paul Hopper
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2012-10-01 | director |
| FCSC | Fibrocell Science Inc | 2009-09-25 | director |
| SCPS | Scopus BioPharma Inc | 2020-12-15 | director |
Paul Hopper Latest Holdings Summary
Paul Hopper currently owns a total of 1 stock. Paul Hopper owns 1,000 shares of EyePoint Pharmaceuticals Inc (EYPT) as of October 1, 2012, with a value of $11,630.
Latest Holdings of Paul Hopper
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2012-10-01 | 1,000 | 11.63 | 11,630 |
Holding Weightings of Paul Hopper
Paul Hopper Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Hopper has made a total of 0 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 1,000 shares on October 1, 2012, which cost Paul Hopper around $16,200.
Insider Trading History of Paul Hopper
- 1
Paul Hopper Trading Performance
GuruFocus tracks the stock performance after each of Paul Hopper's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Hopper is -25.31%. GuruFocus also compares Paul Hopper's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Hopper within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Hopper's insider trading performs compared to the benchmark.
Performance of Paul Hopper
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.32 | | | | | |
| Relative Return to S&P 500(%) | -3.15 | | | | | |
Paul Hopper Ownership Network
Ownership Network List of Paul Hopper
Ownership Network Relation of Paul Hopper
Paul Hopper Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
Paul Hopper is the director of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, Paul Hopper made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 23,240 shares, with a net purchase of 23,240 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
Paul Hopper Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Hopper. You might contact Paul Hopper via mailing address: 7982 Doug Hill, San Diego Ca 92127.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
